Ordering
Available Variants100 mg
CHA.27337-100mg
Price
€48.48
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHA.27337-100mg | €48.48 |
analytical standard
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C16H21NO2 · HCl |
|---|---|
| CAS Number | 318-98-9 |
| Molecular Weight | 295.80 |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
| PubChem Substance ID | 329756000 |
| EC Number | 206-268-7 |
| Beilstein/REAXYS Number | 4164259 |
| MDL number | MFCD00012558 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 |
| Hazard Classifications | Acute Tox. 4 Oral |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
(±)-Propranolol hydrochloride, with a CAS number of 318-98-9, is a non-selective beta-adrenergic receptor blocker commonly utilized in the management of various cardiovascular conditions, including hypertension, angina pectoris, and arrhythmias. As a hydrochloride salt, it exhibits enhanced water solubility, facilitating its formulation into various pharmaceutical preparations. The compounds chemical structure consists of a racemic mixture of two enantiomers, which contribute to its overall pharmacological profile. Propranolol hydrochloride is well absorbed orally and undergoes extensive first-pass metabolism, resulting in a relatively short plasma half-life. Its therapeutic effects are attributed to the blockade of beta-1 and beta-2 adrenergic receptors, leading to decreased heart rate, contractility, and blood pressure. The drugs efficacy and safety profile have been extensively studied, establishing it as a valuable treatment option for patients with cardiovascular diseases.
